Full Length Research Paper
References
|
Allcock S, Young EH, Holmes M, Gurdasani D, Dougan G, Sandhu MS, Solomon L, Török ME (2017). Antimicrobial resistance in human populations: challenges and opportunities. Global Health, Epidemiology and Genomics 2. |
|
|
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, Nisar MA, Alvi RF, Aslam MA, Qamar MU, Salamat MKF (2018). Antibiotic resistance: a rundown of a global crisis. Infection and Drug Resistance 11:1645. |
|
|
Bartlett JG, Gilbert DN, Spellberg B (2013). Seven ways to preserve the miracle of antibiotics. Clinical Infectious Diseases 56(10):1445-1450. |
|
|
Bengtsson-Palme J, Kristiansson E, Larsson DJ (2017). Environmental factors influencing the development and spread of antibiotic resistance. FEMS Microbiology Reviews 42(1):fux053. |
|
|
Centres for Disease Control and Prevention (2013). Antibiotic / Antimicrobial Resistance (AR/AMR). Retrieved from: |
|
|
ECDC (2015). European food safety authority, the European centre for disease prevention and control: the European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2013. EFSA Journal 13:3991. |
|
|
Hay SI, Rao PC, Dolecek C, Day NP, Stergachis A, Lopez AD, Murray CJ (2018). Measuring and mapping the global burden of antimicrobial resistance. BMC Medicine 16(1):78. |
|
|
Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, Jarlier V, Voss A, Pittet D (2013). Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrobial Resistance and Infection Control 2(1):31. |
|
|
Hwang AY, Gums JG (2016). The emergence and evolution of antimicrobial resistance: Impact on a global scale. Bioorganic and Medicinal Chemistry 24(24):6440-6445. |
|
|
KPMG L (2014). The Global Economic Impact of Anti-microbial Resistance. KPMG LLP. |
|
|
Landers TF, Cohen B, Wittum TE, Larson EL (2012). A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Reports 127(1):4-22. |
|
|
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C (2013). Antibiotic resistance-the need for global solutions. The Lancet Infectious Diseases 13(12):1057-1098. |
|
|
Maragakis LL, Perencevich EN, Cosgrove SE (2008). Clinical and economic burden of antimicrobial resistance. Expert Review of Anti-Infective Therapy 6(5):751-763. |
|
|
Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV (2018). Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrobial Resistance and Infection Control 7(1):58. |
|
|
O'Neill JIM (2014). Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Review on Antimicrobial Resistance 20:1-16. |
|
|
Ohl CA, Dodds AES (2011). Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clinical Infectious Diseases 53(suppl_1):S23-S28. |
|
|
Parveen S, Lukasik J, Scott TM, Tamplin ML, Portier KM, Sheperd S, Farrah SR (2006). Geographical variation in antibiotic resistance profiles of Escherichia coli isolated from swine, poultry, beef and dairy cattle farm water retention ponds in Florida 1. Journal of Applied Microbiology 100(1): 50-57. |
|
|
Pruden A, Arabi M, Storteboom HN (2012). Correlation between upstream human activities and riverine antibiotic resistance genes. Environmental Science and Technology 46(21):11541-11549. |
|
|
Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J (2009). Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases 49(8):1175-1184. |
|
|
Rolain JM, Baquero F (2016). The refusal of the society to accept antibiotic toxicity: missing opportunities for therapy of severe infections. Clinical Microbiology and Infection 22(5):423-427. |
|
|
Sahoo KC (2012). Antibiotic resistance and environmental factors: focusing on the situation in Odisha, India. Inst för folkhälsovetenskap/Dept of Public Health Sciences. |
|
|
Schwartz KL, Achonu C, Brown KA, Langford B, Daneman N, Johnstone J, Garber G (2018). Regional variability in outpatient antibiotic use in Ontario, Canada: a retrospective cross-sectional study. CMAJ Open 6(4):E445. |
|
|
Shrestha P, Cooper BS, Coast J, Oppong R, Thuy NDT, Phodha T, Celhay O, Guerin PJ, Wertheim H, Lubell Y (2018). Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use. Antimicrobial Resistance and Infection Control 7(1):98. |
|
|
Smith RD, Coast J (2012). The economic burden of antimicrobial resistance: why it is more serious than current studies suggest. Technical Report. London School of Hygiene and Tropical Medicine, London. |
|
|
Tacconelli E, Pezzani MD (2019). Public health burden of antimicrobial resistance in Europe. The Lancet Infectious Diseases 19(1):4-6. |
|
|
Tam CC, O'Brien SJ (2016). The economic cost of campylobacter, norovirus and rotavirus disease in the United Kingdom. PloS One 11(2):e0138526. |
|
|
Taylor J, Hafner M, Yerushalmi E, Smith R, Bellasio J, Vardavas R, Bienkowska-Gibbs T, Rubin J (2014). Estimating the economic costs of antimicrobial resistance: model and results. Santa Monica, CA: RAND Corporation. |
|
|
Ventola CL (2015). The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics 40(4):277. |
|
|
World Health Organization (WHO) (2017). What is antimicrobial resistance? Retrieved from |
|
|
Wright GD (2014). Something old, something new: revisiting natural products in antibiotic drug discovery. Canadian Journal of Microbiology 60(3):147-154. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
